Overview
Oral care leader's Q4 net sales rose 5.8%, beating analyst expectations
Adjusted EPS for Q4 beat analyst expectations
GAAP EPS declined due to $794 mln impairment charges in skin health business
Outlook
Colgate-Palmolive expects 2026 net sales growth of 2% to 6%
Company anticipates organic sales growth of 1% to 4% in 2026
Colgate-Palmolive expects gross profit margin expansion in 2026
Result Drivers
ORAL CARE AND PET NUTRITION - Growth in oral care and pet nutrition drove Q4 sales, excluding private label impact
IMPAIRMENT CHARGES - $794 mln impairment charges in skin health business affected GAAP EPS
MARKET SHARE - Colgate maintained strong global market share in toothpaste and manual toothbrushes
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Sales | Beat | $5.23 bln | $5.12 bln (12 Analysts) |
Q4 Adjusted EPS | Beat | $0.95 | $0.91 (16 Analysts) |
Q4 EPS | -$0.05 |
Press Release: ID:nBw7DrpyXa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Comments